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Abstract We use site-directed mutagenesis to clarify the role of
effector-mediated oligomerization changes on the modulation of
the activity of Escherichia coli carbamoyl phosphate synthetase
(CPS) by its allosteric activator ornithine and its inhibitor UMP.
The regulatory domain mutations H975L, L990A and N992A
abolished, and N987V decreased CPS oligomerization. The
oligomerization domain mutation L421E prevented tetramer but
not dimer formation. None of the mutations had drastic effects
on enzyme activity or changed the sensitivity or apparent affinity
of CPS for ornithine and UMP. Our findings exclude the
involvement of oligomerization changes in the control of CPS
activity, and show that CPS dimers are formed by the
interactions across regulatory domains, and tetramers by the
interactions of two dimers across the oligomerization domains. A
mechanism for effector-mediated changes of the oligomerization
state is proposed. ß 2002 Federation of European Biochemical
Societies. Published by Elsevier Science B.V. All rights re-
served.
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1. Introduction
Escherichia coli carbamoyl phosphate synthetase (CPS), a
heterodimer of 41.4 and 117.7 kDa subunits, catalyzes the ¢rst
step in the routes of arginine and pyrimidine biosynthesis, and
is feed-back inhibited by UMP and activated by IMP and
ornithine [1]. Although the mechanism of the CPS reaction,
catalyzed by the large subunit, is relatively well understood,
consisting of two analogous steps of bicarbonate and carba-
mate phosphorylation and an intermediate step of carbamate
synthesis from carboxyphosphate and ammonia, little is
known about the mechanism of modulation of the activity
by the allosteric e¡ectors [1]. UMP and IMP bind at the
same site in the C-terminal 20-kDa domain of the large sub-
unit [2^7], called the regulatory domain, and ornithine binds
at the boundary between this domain and the carbamate
phosphorylation domain [5]. The sites of binding of the e¡ec-
tors are far from the sites of carbamate and bicarbonate phos-
phorylation or from the intramolecular tunnel that allows the
migration of carbamate between the phosphorylation centers
[5^7]. Since the enzyme heterodimers associate into oligomers
and the e¡ectors strongly in£uence the oligomerization state
of the enzyme, UMP favoring dimers and ornithine favoring
tetramers (the term monomer refers to the CPS heterodimer;
dimer, trimer and tetramer refer to the association of 2, 3 or
4 CPS heterodimers), there has been discussion on the possi-
bility that the e¡ectors modulate enzyme activity by altering
CPS oligomerization [1,8^11]. In the crystal structures of CPS
in the presence of ornithine or of ornithine and IMP, the
enzyme is a tetramer in which contacts exist between the reg-
ulatory domains of each pair of enzyme molecules, involving
residues that are near the binding site for the e¡ector nucle-
otide (Fig. 1A^C) [6^7]. Additional intermolecular contacts
are provided by hydrophobic residues of the oligomerization
domain of the large CPS subunit [6]. In the tetramer two
given enzyme molecules are connected either through the reg-
ulatory domain or through the oligomerization domain, but
not through both types of contacts [6]. We have prepared CPS
mutants with amino acid changes in the regulatory or the
oligomerization domain that would be expected to hamper
oligomer formation. Leu421 has been replaced by glutamate
(L421E), to create repulsive forces that may interfere with the
association of the oligomerization domains (Fig. 1D) [6], and
hydrophobic interactions or hydrogen bridges linking the reg-
ulatory domains of interacting CPS molecules (Fig. 1A^C) [6]
have been eliminated by changing Leu990 or Asn992 to ala-
nine, His975 to leucine or Asn987 to valine. The double and
triple mutants H975L/N987V and L421E/H975L/N987V have
also been prepared and analyzed. Our ¢ndings exclude the
involvement of oligomerization changes in e¡ector control
of CPS activity, and show that CPS dimers are formed by
the interactions across regulatory domains, and tetramers by
the interactions of two dimers across the oligomerization do-
mains. A mechanism for e¡ector-mediated changes of the oli-
gomerization state is proposed.
As this paper was being submitted a publication appeared
[14] reporting the e¡ects on oligomerization and enzyme ac-
tivity of the mutations N987D and L421E. The results in that
paper are discussed on the light of our present results.
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2. Materials and methods
2.1. Site-directed mutagenesis, expression and puri¢cation of mutant
enzymes
Standard protocols were used for transformation of E. coli and for
isolation and digestion of DNA [15]. pLLK12 [16] which carries the
carAB genes inserted in pUC19 (carA and carB encode the small and
large CPS subunits) was mutated at will using the Transformer Site-
Directed Mutagenesis Kit (from Clontech) [17] and appropriated mu-
tagenic primers. After mutant plasmid synthesis with a high ¢delity T4
polymerase (from Ecogen), and transformation of BMH 71-18 mutS
E. coli cells (mismatch repair de¢cient; from Clontech), plasmids car-
rying the desired mutation(s) were isolated from ampicillin-resistant
colonies. The mutations were con¢rmed by DNA sequencing (Servicio
de Sequenciacio¤n, IBMCP-CSIC, Valencia, Spain), and in all cases
retromutation to the wild type was used to prove that the e¡ects
observed were due to the mutation. Wild type and mutant CPS forms
were expressed from the corresponding plasmids in E. coli strain
L814, which has a deletion of carAB [16], and were puri¢ed as
described [4], yielding preparations of 85^95% purity (based on
Coomassie-stained SDS^PAGE).
2.2. Gel ¢ltration chromatography
Puri¢ed CPS, either wild type or mutant, was incubated 15 min at
24‡C in the column solution, at the indicated concentration, prior to
application in 0.05 ml to a Superdex 200 HR 10/30 column that was
equilibrated and eluted at 24‡C with 0.1 M KPi, pH 8.0, containing
when indicated 0.1 mM UMP or 10 mM ornithine. Molecular masses
were estimated from plots of Kav values versus the molecular masses
of marker proteins (Fig. 2B). Kav = (Ve3Vo)/(Vt3Vo), where Ve is the
elution volume (determined by protein assay at OD280 and by SDS^
PAGE), Vo is the excluded volume (determined with blue dextran)
and Vt is the column bed volume.
3. Results and discussion
3.1. In£uence of the mutations on CPS oligomerization
Wild type and mutant CPS forms were soluble and repre-
sented 20^40% of the soluble bacterial protein. As expected
[1,8^11], at high concentration and in the presence of orni-
thine, wild type CPS was a tetramer, as shown from its mo-
lecular mass of 640 kDa, estimated by gel ¢ltration (Table 1;
Fig. 2). At low concentrations or in the presence of UMP,
CPS was dimeric, whereas at high concentration, in absence of
e¡ectors, it behaved as a dissociating system possibly re£ect-
ing the dimer^tetramer equilibrium (Table 1). Of the regula-
tory domain mutations (Fig. 2; Table 1) L990A, N992A and
H975L (alone or as a part of the multiple mutants H975L/
N987V and L421E/H975L/N987V) abolished oligomer forma-
tion even at high CPS concentration or in the presence of
ornithine (mass estimates, 140^170 kDa). Among regulatory
domain mutants, only N987V was reminiscent of wild type
CPS, (Fig. 2; Table 1), since at high concentration it aggre-
gated in the presence of ornithine, it formed dimers in the
C
Fig. 1. Ribbon representation of the interface between regulatory
domains (A) and details thereof (B and C), and of the interface be-
tween oligomerization domains (D). Interacting residues are shown
in ball and stick representation and are labeled with the residue
number. Colors are used to di¡erentiate the polypeptide chains and
residues of di¡erent enzyme molecules. Bound IMP (which shares
the binding site with UMP, [4] ; UMP^CPS complexes have not
been reported) is colored blue in stick representation. In B and C
hydrogen bonds are detailed; those in C link main chain oxygens
(not represented) to the side chain of N987. Drawn with MOL-
SCRIPT [12] and Raster3D [13], using the coordinates deposited for
CPS (PDB 1ce8) [7].
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presence of UMP, and its mass exceeded that of the monomer
without e¡ectors. Nevertheless, the estimated masses were
lower for N987V than for wild type CPS, and thus this muta-
tion also hampered somewhat oligomerization. Judged from
the mass estimates, the oligomerization domain mutation
L421E reduced the aggregation form of concentrated CPS in
the presence of ornithine to dimers (instead of the tetramer
observed with wild type CPS). In the presence of UMP or
without e¡ectors the e¡ects of L421E were less clear, although
the elution positions suggest that dimers may also predomi-
nate at high protein concentration (Table 1).
Overall, as expected, all the mutations decreased the oligo-
merization of CPS. The regulatory domain mutations that
abolished the central hydrophobic interaction mediated by
Leu990 (Fig. 1A) (L990A) or the three-hydrogen bond net-
work mediated by His975 and Ans992 (Fig. 1B) had the great-
est e¡ect. The substantial oligomerization capacity of the
N987V mutant indicates a less important role of the two hy-
drogen bonds mediated by Asn987 (Fig. 1C), or their partial
replacement by new contacts between the hydrophobic side
chains of the valine residues introduced by the mutation.
Since regulatory domain mutations can render the enzyme
unable to form any kind of oligomer, oligomerization domain
interactions appear too weak to form stable dimers. In con-
trast, the oligomerization domain mutation L421E decreased
tetramer but did not prevent dimer formation, indicating that
the dimer is formed by interactions of two enzyme molecules
across their regulatory domains. Thus, binding must be stron-
ger across the regulatory than across the oligomerization do-
mains, in agreement with the larger number of contacts medi-
ated by the regulatory domain (Fig. 1). The ability of the
oligomerization domain to mediate aggregation of preformed
dimers to tetramers, but not of monomers to dimers, is under-
standable, since the free energy of binding of two preformed
dimers to form the tetramer, given by the expression
vG0dimer = 2 vG0olig+vGS, should be considerably more neg-
ative than the free energy of binding across the oligomeriza-
tion domain of two enzyme monomers, vG0olig. In the ex-
pression for vG0dimer, vGS is the ‘connection Gibbs energy’
[18], which re£ects the very high e¡ective concentration (typ-
icallyE100 M for small molecules; see for example [19]) of
the second pair of interacting oligomerization domains after
the ¢rst pair has bound.
Since UMP prevents association of CPS dimers into tet-
ramers, its binding into the regulatory domain must hamper
the interactions across the oligomerization domain, despite
the fact that this domain is very far from the regulatory do-
main [5]. Perhaps UMP, by bridging the interaction interface
of the regulatory domain to the remainder of the enzyme
molecule (Fig. 1A), alters the orientation of the latter with
respect to the interface and thus the position of the oligome-
rization domain, resulting in the misalignment of the two
oligomerization domains of one dimer for simultaneous con-
tact with the corresponding domains of another dimer. Orni-
thine, by binding at the boundary between regulatory and
carbamate phosphorylation domains [5], may also in£uence
the relative orientation of the bulk of the enzyme molecule
with respect to the regulatory domain, and therefore it may
act as UMP but in an opposite sense. The determination of
the crystal structure of CPS^UMP complexes will be essential
to test these proposals.
3.2. In£uence of the mutations on the catalytic activity and
allosteric regulation
None of the mutations, including those that prevented com-
pletely enzyme oligomerization, or even the triple mutation
a¡ecting both the regulatory and the oligomerization do-
mains, had an important e¡ect on the enzyme activity in the
Fig. 2. Gel ¢ltration chromatography. A: Chromatographic pro¢les
of wild type and mutant enzymes (30 mg/ml) loaded on a Superdex
200 HR column and eluted in the presence of 10 mM ornithine.
(F) Wild type; (E) N987V; (a) L421E; (b) N992A; (O) H975L;
(R) L990A; (7) H975L/N987V; (8) L421E/H975L/N987V. B: Plot
of Kav as a function of the mass of standard proteins: (1) ovoalbu-
min (43 kDa); (2) bovine serum albumin (67 kDa); (3) alcohol de-
hydrogenase (150 kDa); (4) aldolase (158 kDa); (5) L-amylase, (200
kDa); (6) catalase (232 kDa); and (7) ferritin (440 kDa). The posi-
tion in the plot of CPS, either wild type (WT) or with the indicated
mutation(s) is indicated by the arrows.
Table 1
Molecular mass estimation by gel ¢ltration through Superdex 200
HR 10/30 of wild type and mutant CPS formsa
E¡ector None UMP 0.1 mM Ornithine 10
mM
Enzyme (mg/ml) 0.5 30 0.5 30 0.5 30
Mutants molecular mass (kDa)
Wild type 290 490 300 315 320 640
L421E 280 400 285 380 235 370
H975L 142 145 165 160 145 145
N987V 190 315 180 295 160 440
L990A 145 145 165 165 145 145
N992A 145 160 160 165 145 158
H975L/N987V 140 150 160 155 145 140
L421E/H975L/N987V 140 150 170 165 140 140
aMethodological details are given in Section 2.
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absence of e¡ectors (Table 2), the rate of the reaction cata-
lyzed by the mutants di¡ering from the wild type by a factor
6 2. The stoichiometry of the reaction, judged from the pro-
duction of ADP and carbamoyl phosphate, agreed within ex-
perimental error with the expectation for the normal reaction
(2 ATP molecules used per carbamoyl phosphate molecule
formed) [1]. Thus, the association between heterodimers is
not required for activity, and the results agree with the infer-
ence derived from the 3-D CPS structure [5^7] that neither the
oligomerization domain or the regulatory domain is involved
in the catalysis of the enzyme reaction or in the transfer of
intermediates between the two phosphorylation sites. Further-
more, the low magnitude of the di¡erences in activity between
wild type and mutant CPS forms strongly suggests that the
oligomerization state has little in£uence on the enzyme activ-
ity. This suggestion is supported also by the observation of
constant speci¢c activity of wild type CPS irrespective of the
enzyme concentration (range tested, 0.015^0.4 mg/ml) or of
the elution position of the enzyme in the gel ¢ltration system
under conditions at which di¡erent oligomeric forms predom-
inate (data not shown; activity was assayed for 1^5 min at
24‡C and, for column fractions, immediately after elution).
Since the modest rate decrease observed with the di¡erent
mutations was not paralleled by a similar decrease in the rates
of the ATPase or ATP synthesis partial reactions (Table 2)
that re£ect the steps of bicarbonate and carbamate phosphor-
ylation, respectively (except for mutant N987V, for which the
complete and the ATPase reactions decreased similarly), the
mutations may interfere somewhat with a reactional step or
process that is not re£ected in the partial reactions, such as
the reaction of carboxyphosphate and ammonia or the migra-
tion of the resulting carbamate to the carbamate phosphory-
lation site. In fact, most mutations increased somewhat the
bicarbonate-dependent ATPase partial reaction, as expected if
water had an easier access to the enzyme-bound carboxyphos-
phate intermediate than in wild type CPS.
Fig. 3 shows that the e¡ects of UMP and of ornithine are
essentially the same for all the mutations tested, irrespective of
the in£uence of the mutation on the oligomerization state of
the enzyme and also irrespective of the enzyme concentration
in the assay (0.015 or 0.4 mg/ml). Under the assay conditions
used, ornithine increased in all cases enzyme activity to a
maximum of approximately 1.75-fold the activity in the ab-
sence of ornithine, with a Ka value of approximately 70 WM.
Similarly, under these assay conditions, UMP decreased the
activity in all cases to a minimum of approximately 6% of the
activity in the absence of any e¡ectors, and the Ki was ap-
proximately 4 WM. The identical e¡ects of UMP and ornithine
Table 2
CPS activity and partial bicarbonate-dependent ATPase and ATP synthesis reactions catalyzed by the wild type and mutant forms of the
enzymea
Activity CPS HCO33 ATPase ATP synthesis
Production of (Wmol/min/mg) CP ADP ADP ATP
Wild type 3.0 5.4 0.22 0.42
L421E 2.5 4.5 0.31 0.39
H975L 1.9 3.7 0.23 0.43
N987V 1.9 3.7 0.43 0.28
L990A 2.1 4.1 0.29 0.39
N992A 2.5 4.9 0.30 0.39
H975L/N987V 1.7 3.5 0.28 0.44
L421E/H975L/N987V 2.0 3.7 0.21 0.45
aCPS activity was assayed at 37‡C in a solution containing 0.1 M Tris^HCl, pH 8.0, 0.1 M KCl, 20 mM NaHCO3, 10 mM glutamine, 7 mM
MgSO4 and 5 mM ATP, determining after 10 min carbamoyl phosphate or ADP [4] production. To assay the HCO33 -dependent partial ATP-
ase activity, glutamine was omitted and 2.5 mM phosphoenolpyruvate, 0.25 mM NADH, 0.04 mg/ml pyruvate kinase and 0.025 mg/ml lactate
dehydrogenase (both ammonia-free) were added, and the production of ADP was monitored at 340 nm. The partial reaction of ATP synthesis
from ADP and carbamoyl phosphate was assayed at 37‡C in a solution containing 0.1 M Tris^HCl, pH 8.0, 0.1 M KCl, 15 mM MgSO4, 15
mM glucose, 5 mM ADP, 5 mM carbamoyl phosphate, 1 mM NADP, 0.1 mg/ml hexokinase and 0.025 mg/ml glucose-6-phosphate dehydroge-
nase, by monitoring the change in OD340.
Fig. 3. In£uence of ornithine and UMP on carbamoyl phosphate
synthesis. Velocities are expressed as a fraction of the velocity of
the same enzyme form in the absence of e¡ectors. The hyperbola
drawn for ornithine activation corresponds to a velocity at in¢nite
ornithine of 1.77 and a KOrna of 70 WM; and that for UMP inhibi-
tion to a velocity at in¢nite UMP of 0.06 and a KUMPi of 4 WM. Ac-
tivity was assayed at 24‡C in a mixture of 40 mM KPi, pH 8.0,
0.1 M KCl, 20 mM NaHCO3, 10 mM glutamine, 4 mM MgSO4,
2 mM ATP, 5 mM phosphoenolpyruvate and 10 U/ml pyruvate ki-
nase, measuring carbamoyl phosphate production [4]. The results
given are those for 0.015 mg/ml enzyme concentrations; essentially
identical results were obtained at 0.4 mg/ml enzyme. (F) Wild type;
(E) N987V; (b) N992A; (a) L421E; (O) H975L; (R) L990A;
(7) H975L/N987V; (8) L421E/H975L/N987V.
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with the wild type and mutant forms of CPS and the small
magnitude of the activity changes caused by the mutations
compared with the inhibition caused by UMP clearly indicate
that the activity changes triggered by the e¡ectors cannot
result from changes in the oligomerization state of the en-
zyme. Since most of the mutants are always monomeric, the
CPS monomer (the K/L-heterodimer) can exhibit di¡erent de-
grees of activity depending on whether ornithine, IMP or
UMP are bound. Clearly, the 3-D structure of the complex
of the enzyme with UMP should be determined and compared
with the corresponding structures with ornithine and/or IMP
to try to determine why UMP is such an strong inhibitor of
the enzyme.
A paper reporting the e¡ects on CPS activity and oligome-
rization, monitored by ultracentrifugation at 0.05^3 mg CPS/
ml, of mutations a¡ecting two of the presently studied resi-
dues, N987D and L421E, either separately or as the double
mutant, has appeared [14] as our manuscript was being pre-
pared for submission. In that report N987D prevented oligo-
merization, and thus, in our mutant N987V the hydrophobic
interactions between the valine residues must compensate in
part for the intermolecular hydrogen bonds that are elimi-
nated by the mutation, as proposed above. The results with
L421E agree in the two studies, although the e¡ects of the
mutations on the apparent a⁄nity of CPS for the allosteric
e¡ectors or on the bicarbonate-dependent ATPase partial re-
action were not studied in [14], as is done here. However, in
Kim and Raushel’s report [14] the e¡ects of the mutations on
the kinetic parameters for ATP in the overall reaction and for
ADP in the partial reaction of ATP synthesis, in the absence
and at ¢xed high concentration of each e¡ector, are examined,
and the equilibrium constants for oligomer formation are es-
timated. Overall, the experimental data in the present report,
in which the e¡ect of mutations a¡ecting a larger number of
residues is analyzed, and in the study of Kim and Raushel are
generally in agreement and complementary.
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